1. Shigetomi, H., Onogi, A., Kajiwara, H., Yoshida, S., Furukawa, N., Haruta, S., ... & Oi, H. Anti-inflammatory actions of serine protease inhibitors containing the Kunitz domain //Inflammation research. – 2010. – Т. 59. – №. 9. – С. 679-687.

2. Sintsova, O. V., Monastyrnaya, M. M., Pislyagin, E. A., Menchinskaya, E. S., Leychenko, E. V., Aminin, D. L., & Kozlovskaya, E. P. Anti-inflammatory activity of a polypeptide from the Heteractis crispa sea anemone //Russian Journal of Bioorganic Chemistry. – 2015. – Т. 41. – №. 6. – С. 590-596.

3. Kobayashi, H., Yoshida, R., Kanada, Y., Fukuda, Y., Yagyu, T., Inagaki, K., ... & Terao, T. Dietary supplementation of soybean kunitz trypsin inhibitor reduces lipopolysaccharideinduced lethality in mouse model //Shock. – 2005. – Т. 23. – №. 5. – С. 441-447.

4. Kobayashi, H., Yoshida, R., Kanada, Y., Fukuda, Y., Yagyu, T., Inagaki, K., ... & Kitanaka, T. A soybean unitz trypsin inhibitor reduces tumor necrosis factor‐α production in ultraviolet‐exposed primary human keratinocytes //Experimental dermatology. – 2005. – Т. 14. – №. 10. – С. 765-774.

5. McCaffrey, T. A., Falcone, D. J., Vicente, D., Du, B., Consigli, S., & Borth, W. Protection of transforming growth factor β activity by heparin and fucoidan //Journal of cellular physiology. – 1994. – Т. 159. – №. 1. – С. 51-59.

6. Molor-Erdene P. et al. Urinary trypsin inhibitor reduces LPS-induced hypotension by suppressing tumor necrosis factor-α production through inhibition of Egr-1 expression //American Journal of Physiology-Heart and Circulatory Physiology. – 2005. – Т. 288. – №. 3. – С. H1265-H1271.

7. Cao, Y. Z., Tu, Y. Y., Chen, X., Wang, B. L., Zhong, Y. X., & Liu, M. H. Protective effect of Ulinastatin against murine models of sepsis: inhibition of TNF-α and IL-6 and augmentation of IL-10 and IL-13 //Experimental and Toxicologic Pathology. – 2012. – Т. 64. – №. 6. – С. 543-547.

8. Day, J. R., Taylor, K. M., Lidington, E. A., Mason, J. C., Haskard, D. O., Randi, A. M., & Landis, R. C. Aprotinin inhibits proinflammatory activation of endothelial cells by thrombin through the protease-activated receptor 1 //The Journal of Thoracic and Cardiovascular Surgery. – 2006. – Т. 131. – №. 1. – С. 1-27.

9. Landis R. C. Protease activated receptors: clinical relevance to hemostasis and inflammation //Hematology/oncology clinics of North America. – 2007. – Т. 21. – №. 1. – С. 103-113.

10. Harig, F., Feyrer, R., Mahmoud, F. O., Blum, U., & Von der Emde, J. Reducing the postpump syndrome by using heparin-coated circuits, steroids, or aprotinin //The Thoracic and cardiovascular surgeon. – 1999. – Т. 47. – №. 0 . – С. 111-118.

11. Baufreton C. et al. Heparin coating with aprotinin reduces blood activation during coronary artery operations //The Annals of thoracic surgery. – 1997. – Т. 63. – №. 1. – С. 50-56

12. Eggert-Kruse W. et al. Relationship of seminal plasma interleukin (IL)-8 and IL-6 with semen quality //Human reproduction. – 2001. – Т. 16. – №. 3. – С. 517-528.

13. Robertson, S.A., Guerin L.R., Bromfield J.J., Branson K.M., Ahlström A.C., Care A.S. Seminal fluid drives expansion of the CD4+ CD25+ T regulatory cell pool and induces tolerance to paternal alloantigens in mice. Biology of reproduction, 2009, 80(5), 10361045.

14. Kubiczkova L. et al. TGF-β–an excellent servant but a bad master //Journal of translational medicine. – 2012. – Т. 10. – №. 1. – С. 183.

15. Sadat Z., Kalahroudi M. A., Saberi F. The effect of short duration sperm exposure on development of preeclampsia in primigravid women //Iranian Red Crescent Medical Journal. – 2012. – Т. 14. – №. 1. – С. 20.

16. Yang L., Pang Y., Moses H. L. TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression //Trends in immunology. – 2010. – Т. 31. – №. 6. – С. 220-227.